Pathalys Pharma
Clinical trials sponsored by Pathalys Pharma, explained in plain language.
-
New drug aims to tame dangerous hormone in dialysis patients
Disease control CompletedThis study tested a drug called PLS240 for people with kidney failure on dialysis who have a related hormone problem called secondary hyperparathyroidism. Over 400 participants were randomly assigned to receive either the real drug or a placebo for about 6 months, followed by an …
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Apr 02, 2026 06:42 UTC
-
New hope for dialysis patients with dangerous hormone imbalance
Disease control CompletedThis study tested a drug called PLS240 for people with kidney failure on dialysis who also have a serious hormone disorder called secondary hyperparathyroidism. In the first part, 362 participants were randomly assigned to receive either the real drug or a placebo for 27 weeks. A…
Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC